Status:
COMPLETED
Use of OraQuick for Screening HIV in Children Less Than Eighteen Months Old
Lead Sponsor:
Thrasher Research Fund
Collaborating Sponsors:
Centers for Disease Control and Prevention
Conditions:
HIV Antibody Testing
Eligibility:
All Genders
1-18 years
Brief Summary
Blood is the most commonly used specimen to test for HIV. In the past 20 years, use of saliva as an alternative specimen for HIV testing has been explored. Today, very sensitive tests have been formul...
Detailed Description
BACKGROUND Serological identification of antibodies to Human Immunodeficiency virus (HIV) in blood is the most widely used method to screen for HIV infection. Use of oral fluid as an alternative to bl...
Eligibility Criteria
Inclusion
- Children aged less than 18 months
- Admission to the Department of Pediatrics for any condition
- Consent from caregiver for HIV testing using both oral fluid and blood r
Exclusion
- Age of more than 18 months
- Refusal of consent by caregiver
- Outpatients
Key Trial Info
Start Date :
December 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2007
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT00378118
Start Date
December 1 2006
End Date
September 1 2007
Last Update
November 6 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Teaching Hospital,Department of Pediatrics
Lusaka, Lusaka Province, Zambia, P/B RW 1